Meta-Analysis with Meta-Regression of Regenerative Medicine Trials

Änne Glass, Peter Donndorf & Günther Kundt
Objectives: Regenerative medicine trials have suggested that intramyocardial bone marrow stem cell (BMSC) transplantation combined with coronary artery bypass surgery (CABG) might improve left ventricular (LV) function, and thus prove to be a new therapeutic option for patients with endstage ischemic[for full text, please go to the a.m. URL]